StimuSIL, Inc.
Biotechnology company · Wilmington, Delaware, United States
StimuSIL, Inc. is a biotechnology company headquartered in Wilmington, Delaware, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $599,988 sold in a notice filed in 2025.
StimuSIL at a glance
What does StimuSIL do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $599,988 sold (2025).
Frequently asked questions about StimuSIL
Where is StimuSIL headquartered?
StimuSIL, Inc. is headquartered in Wilmington, Delaware, United States.
What does StimuSIL do?
StimuSIL, Inc. is a biotechnology company.
When was StimuSIL founded?
The earliest incorporation on record for StimuSIL, Inc. is in 2021, according to public company registers.
Similar companies
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- OpiAID, LLCWilmington, North Carolina, United States
- Synnovation Therapeutics, Inc.Wilmington, Delaware, United States
- Treadwell CorporationWilmington, North Carolina, United States
- NiKang Therapeutics, Inc.Wilmington, Delaware, United States
- GPN Vaccines, Inc.Wilmington, Delaware, United States
- Advanced Materials Technology, Inc.Wilmington, Delaware, United States
- Compact Membrane Systems, Inc.Wilmington, Delaware, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences